Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1186 AL 1200

A Comprehensive Review of Alzheimer's Association with Related Proteins: Pathological Role and Therapeutic Significance

Kumar D, Sharma A, Sharma L.

Curr Neuropharmacol. 2020;18(8):674-695. doi: 10.2174/1570159X18666200203101828.

Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease

Singh AK, Verma S.

Indian J Ophthalmol. 2020 Apr;68(4):555-561. doi: 10.4103/ijo.IJO_999_19.

Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine

Wang HC, Liu NY, Zhang S, Yang Y, Wang ZY, Wei Y, Liu JG, Pei H, Li H.

Chin J Integr Med. 2020 Mar;26(3):212-218. doi: 10.1007/s11655-019-2718-2. Epub 2020 Mar 16.

Biochemical Markers in Alzheimer's Disease

Rabbito A, Dulewicz M, Kulczyńska-Przybik A, Mroczko B.

Int J Mol Sci. 2020 Mar 14;21(6):1989. doi: 10.3390/ijms21061989.

Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease

Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M.

Int J Mol Sci. 2020 Mar 14;21(6):1992. doi: 10.3390/ijms21061992.

Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial

André C, Rehel S, Kuhn E, Landeau B, Moulinet I, Touron E, Ourry V, Le Du G, Mézenge F, Tomadesso C, de Flores R, Bejanin A, Sherif S, Delcroix N, Manrique A, Abbas A, Marchant NL, Lutz A, Klimecki OM, Collette F, Arenaza-Urquijo EM, Poisnel G, Vivien D, Bertran F, de la Sayette V, Chételat G, Rauchs G; Medit-Ageing Research Group.

JAMA Neurol. 2020 Jun 1;77(6):716-724. doi: 10.1001/jamaneurol.2020.0311.

The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients

Gündüztepe Y, Bukan N, Zorlu E, Karaman Y, Andaç Topkan T, Gurbuz N, Neşelioğlu S, Erel Ö.

J Clin Neurosci. 2020 May;75:188-194. doi: 10.1016/j.jocn.2019.12.026. Epub 2020 Mar 27.

Functional roles of circular RNAs in Alzheimer's disease

Huang JL, Su M, Wu DP.

Ageing Res Rev. 2020 Jul;60:101058. doi: 10.1016/j.arr.2020.101058. Epub 2020 Mar 29.

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease

Janelidze S, Stomrud E, Smith R, Palmqvist S, Mattsson N, Airey DC, Proctor NK, Chai X, Shcherbinin S, Sims JR, Triana-Baltzer G, Theunis C, Slemmon R, Mercken M, Kolb H, Dage JL, Hansson O.

Nat Commun. 2020 Apr 3;11(1):1683. doi: 10.1038/s41467-020-15436-0.

Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?

Mullane K, Williams M.

Biochem Pharmacol. 2020 Jul;177:113945. doi: 10.1016/j.bcp.2020.113945. Epub 2020 Apr 2.

Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies

Zetterberg H, Bendlin BB.

Mol Psychiatry. 2021 Jan;26(1):296-308. doi: 10.1038/s41380-020-0721-9. Epub 2020 Apr 6.

The Role of Nutrition in Individualized Alzheimer's Risk Reduction

Amini Y, Saif N, Greer C, Hristov H, Isaacson R.

Curr Nutr Rep. 2020 Jun;9(2):55-63. doi: 10.1007/s13668-020-00311-7.

ER stress activates immunosuppressive network: implications for aging and Alzheimer's disease

Salminen A, Kaarniranta K, Kauppinen A.

J Mol Med (Berl). 2020 May;98(5):633-650. doi: 10.1007/s00109-020-01904-z. Epub 2020 Apr 11.

Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study

Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, Wolz R, Stephens A, Gismondi R, Buckely C, Gispert JD, Schmidt M, Ford L, Ritchie C, Farrar G, Barkhof F, Molinuevo JL; AMYPAD Consortium.

Alzheimers Dement. 2020 May;16(5):750-758. doi: 10.1002/alz.12069. Epub 2020 Apr 12.

New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer's disease

Park SA, Han SM, Kim CE.

Exp Mol Med. 2020 Apr;52(4):556-568. doi: 10.1038/s12276-020-0418-9. Epub 2020 Apr 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias